Tiedemann Advisors’s Gilead Sciences GILD Stock Holding History

Tiedemann Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-17,373	Closed	-$1.1M	–	310
2019 Q3	$1.1M	Buy	+17,373	New	+$1.14M	0.05%	167
2018 Q4	–	Sell	-15,324	Closed	-$1.18M	–	434
2018 Q3	$1.18M	Sell	15,324 -12	-0.1%	-$906	0.07%	154
2018 Q2	$1.09M	Buy	15,336 +4,940	+48%	+$349K	0.07%	155
2018 Q1	$784K	Buy	+10,396	New	+$826K	0.05%	161
2017 Q4	–	Sell	-3,543	Closed	-$281K	–	269
2017 Q3	$281K	Sell	3,543 -15,047	-81%	-$1.15M	0.03%	289
2017 Q2	$1.32M	Buy	18,590 +436	+2%	+$29K	0.1%	168
2017 Q1	$1.23M	Buy	+18,154	New	+$1.28M	0.1%	161

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Tiedemann Advisors's GILD Position: Q4 2019 in Review

Tiedemann Advisors sold out of Gilead Sciences (GILD) in Q4 2019, closing a stake of 17,373 shares — an estimated $1.1M sold.

Tiedemann Advisors first reported a position in GILD in Q1 2017 and held it in 7 quarters. The position peaked at $1.32M in Q2 2017. 1,555 funds tracked by Wall St. Rank hold GILD as of Q4 2019.

Tiedemann Advisors reported no remaining Gilead Sciences position as of Q4 2019 after selling out during the quarter.
Tiedemann Advisors sold 17,373 Gilead Sciences shares in Q4 2019, an estimated $1.1M.
Tiedemann Advisors first reported a position in Gilead Sciences in Q1 2017 and held it in 7 quarters.
Tiedemann Advisors's Gilead Sciences position peaked at $1.32M in Q2 2017.
1,555 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2019.

Based on Tiedemann Advisors's 13F filing for Q4 2019, filed 12 Feb 2020.